[EN] COMPOUNDS AND METHODS<br/>[FR] COMPOSÉS ET PROCÉDÉS
申请人:GLAXOSMITHKLINE LLC
公开号:WO2013066836A1
公开(公告)日:2013-05-10
The present invention relates to compounds that inhibit histone deacetylase (HDAC) enzymes, the preparation of these compounds or salts of said compound, the use of these compounds in the treatment of neurodegenerative diseases or conditions ameliorated by inhibition of HDAC activity and pharmaceutical compositions that are comprised of these compounds.
Direct Coupling of Arylacetonitriles and Primary Alcohols to α-Alkylated Arylacetamides with Complete Atom Economy Catalyzed by a Rhodium Complex-Triphenylphosphine- Potassium Hydroxide System
作者:Feng Li、Xiaoyuan Zou、Nana Wang
DOI:10.1002/adsc.201401013
日期:2015.5.4
A direct synthesis of α‐alkylated arylacetamides from arylacetonitriles and primaryalcohols has been accomplished for the first time. In the presence of the rhodium complex [Rh(cod)Cl]2/triphenylphosphine/potassiumhydroxidesystem, the desired α‐alkylated arylacetamides were obtained in 74–92% yield under microwave conditions. The experimental results in this paper are in sharp contrast with previous
Compounds of the general formula (I) in which the substituents R, R
1
, R
2
, R
3
, R
4
, R
5
and R
6
are each as defined in claim 1 have renin-inhibiting properties and can be used as medicaments.